Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies

• Príomhchruthaitheoirí: Philippe-Henri Secretan (Údar), Maxime Annereau (Údar), Willy Kini-Matondo (Údar), Bastien Prost (Údar), Jade Prudhomme (Údar), Lina Bournane (Údar), Muriel Paul (Údar), Najet Yagoubi (Údar), Hassane Sadou-Yayé (Údar), Bernard Do (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2022-08-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Nirmatrelvir is an antiviral drug approved for the treatment of COVID-19. The available dosage form consists of tablets marketed under the brand name PAXLOVID^®. Although knowledge of nirmatrelvir's intrinsic stability may be useful for any potential development of other p...